Management of Diffuse Low-Grade Glioma: The Renaissance of Robust Evidence

Management of Diffuse Low-Grade Glioma: The Renaissance of Robust Evidence

The surgical management of diffuse low-grade gliomas (DLGGs) has undergone a paradigm shift toward striving for maximal safe resection when feasible. While extensive observational data supports this transition, unbiased evidence in the form of high quality randomized-controlled trials (RCTs) is lack...

Full description

Bibliographic Details
Main Authors: Karanbir Brar, Laureen D. Hachem, Jetan H. Badhiwala, Christine Mau, Brad E. Zacharia, Fabio Ynoe de Moraes, Farhad Pirouzmand, Alireza Mansouri
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
diffuse low-grade glioma
neurosurgery
randomized controlled trials
neuro-oncology
artificial intelligence
machine learning
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.575658/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.575658/full

Similar Items